Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'bax inhibitor peptide negative control'

Search results for: 'bax inhibitor peptide negative control'

Items 71-80 of 97

Page
per page
  1. BMS-794833
    B1438 BMS-794833
    Target: MET|Flk-1
    Summary: Met/VEGFR-2 inhibitor,potent and ATP-competitive
      ≥23.45 mg/mL
  2. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  3. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  4. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  5. Vatalanib
    A3969 Vatalanib
     1 Citation
    Target: VEGFR
    Summary: VEGFR-1/-2 inhibitor,cell-permeable
      ≥16.85 mg/mL
  6. AZD2932
    B5835 AZD2932
    Target: FLT3|VEGFR|PDGFR|c-Kit
    Summary: inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit
      Soluble in DMSO
  7. Vatalanib (PTK787) 2HCl
    A1778 Vatalanib (PTK787) 2HCl
    Target: VEGFR
    Summary: Tyrosine kinase receptor inhibitor
      ≥21 mg/mL
  8. LDK378
    A8328 LDK378
    Target: ALK
    Summary: Potent ALK inhibitor
      insoluble in H2O; ≥13.95 mg/mL
  9. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  10. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL

Items 71-80 of 97

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 7item
  2. Axl 4item
  3. ALK 3item
  4. c-FMS 1 item
  5. c-Kit 2item
  6. c-MET 9item
  7. c-RET 3item
  8. CSF-1R 2item
  9. EGFR 18item
  10. FAK 3item
  11. FGFR 4item
  12. FLT3 4item
  13. HER2 8item
  14. IGF1R 3item
  15. IRAK 2item
  16. ITK 1 item
  17. LRRK2 4item
  18. PDGFR 8item
  19. Pyk2 1 item
  20. Spleen Tyrosine Kinase (Syk) 3item
  21. Src 6item
  22. Tie-2 2item
  23. Trk 2item
  24. VEGFR 18item
Specificity
  1. Selective 59item
Reversibility
  1. Reversible 5item
  2. Irreversible 5item
Target
  1. Histone Deacetylases (HDACs) 1 item
  2. Raf 4item
  3. Aurora Kinases 2item
  4. CSF-1R 4item
  5. MER 1 item
  6. FLT3 9item
  7. Eph Receptors 1 item
  8. VEGFR 24item
  9. PDGFR 15item
  10. c-Kit 8item
  11. RET 1 item
  12. IRAK 2item
  13. Bcr-Abl 7item
  14. FGFR 8item
  15. MET 5item
  16. Src 8item
  17. Trk Receptors 2item
  18. STAT 1 item
  19. EGFR 17item
  20. FAK 3item
  21. JAK 2item
  22. Syk 3item
  23. ErbB 4item
  24. c-MET 6item
  25. PKC 1 item
  26. Lyn 1 item
  27. HER2 1 item
  28. Pyk2 2item
  29. LRRK2 4item
  30. Insulin and Insulin-like Receptors 3item
  31. ALK 3item
  32. Angiotensin-Converting Enzymes (ACEs) 1 item
  33. Tie-2 3item
  34. Ron 1 item
  35. 5-Lipoxygenases 1 item
  36. Insulin Receptors 1 item
  37. IRG-1R 1 item
  38. ZAP-70 1 item
  39. Flk-1 1 item
  40. c-RET 2item
  41. TAM kinase 1 item
  42. KDR 1 item
  43. Fyn kinase 1 item
  44. Abl kinases 1 item
  45. AXL 1 item
  46. c-Fms tyrosine kinase 1 item
  47. insulin 1 item
  48. Mer tyrosine kinase 1 item
  49. ErbB-2 1 item
  50. ITK 1 item
  51. DCLK2 1 item
  52. PTK 1 item
  53. Flk1 1 item
  54. YES 1 item
  55. Fyn 1 item
  56. enoyl-acyl-carrier protein reductase 1 item
  57. tropomyosin receptor kinase 1 item
  58. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Adrenocortical Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 12item
  7. Cancer 66item
  8. Cervical Cancer 1 item
  9. Cholangiocarcinoma 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 3item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 8item
  14. Glioblastoma 6item
  15. Glioma 1 item
  16. Hepatocellular Carcinoma 3item
  17. Leukemia 2item
  18. Liver Cancer 2item
  19. Lung Cancer 3item
  20. Lung Carcinoma 2item
  21. Lymphoma 4item
  22. Melanoma 1 item
  23. Multiple Myeloma 2item
  24. Non-small Cell Lung Cancer 3item
  25. Ovarian Cancer 5item
  26. Pancreatic Cancer 9item
  27. Prostate Cancer 5item
  28. Renal Cancer 1 item
  29. Renal Cell Carcinoma 1 item
  30. Rheumatoid Arthritis 2item
  31. Thyroid Cancer 2item